BALF nitrite as an indicator of inflammation in children with cystic fibrosis

Respiration

Volumn 71, Issue 6, 2004, Pages 625-629

  Çetin, Ilker ^a   Özçelik, Uǧur ^a   Göçmen, Ayhan ^a   Kiper, Nural ^a   Doǧru, Deniz ^a   Yalçin, Ebru ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bronchoalveolar lavage fluid; Cystic fibrosis; Cytokines; Nitrite

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 18; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; ERYTHROCYTE SEDIMENTATION RATE; FIBEROPTIC BRONCHOSCOPY; FUNGUS CULTURE; HAEMOPHILUS; HAEMOPHILUS PARAHEMOLYTICUS; HAEMOPHILUS PARAINFLUENZAE; HUMAN; INFLAMMATION; KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; LUNG LAVAGE; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BLOOD SEDIMENTATION; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CYSTIC FIBROSIS; CYTOKINES; HUMANS; INTERLEUKIN-8; LEUKOCYTE COUNT; NITRITES;

EID: 11844288355     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081764     Document Type: Article

References (39)

1. Welsh MJ, Tsui IT, Boat TF, Beaudet AL: Cystic fibrosis; in Scriver CL, Beaudet AL, Sly WS (eds): The Metabolic Bases of Inherited Disease. New York, McGraw, 1995, pp 3799-3876.
2. Seibert FS, Tabcharan JA, Chang XB: cAMP-dependent protein kinase-mediated phosphorylation of cystic fibrosis transmembrane conductance regulator residue and its role in channel activation. J Biol Chem 1995;270:2158-2162.
3. Gilligan PH: Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991;4:35-51.
4. Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R: The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995;20:63-70.
5. Hull J, Skinner W, Robertson C, Phelan P: Elemental content of airway surface liquid from infants with cystic fibrosis. Am J Respir Crit Care Med 1998;157:10-14.
6. Noah TL, Black HR, Cheng PW, Wood RE, Leigh MW: Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 1997;175:638-647.
7. Muhlebach MS, Stewart PW, Leigh MW, Noah TL: Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999;160:186-191.
8. Saltini C, Hance AJ, Ferrans VJ, Basset F, Bitterman PB, Crystal RG: Accurate quantification of cells recovered by bronchoalveolar lavage. Am Rev Respir Dis 1984;130:650-658.
9. Ratjen F, Gartig S, Wiesemann HG, Grasemann H: Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis. Respir Med 1999;93:579-583.
10. Head CA: Nitric oxide and the lung: An overview. Artif Organs 1997;21:5-9.
11. Barnes PJ, Belvisi MG: Nitric oxide and lung disease. Thorax 1993;48:1034-1043.
12. Grasemann H, Ratjen F: Cystic fibrosis lung disease: The role of nitric oxide. Pediatr Pulmonol 1999;28:442-448.
13. Kharitonov SA, Yates D, Barnes PJ: Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995;8:295-297.
14. Kharitonov SA, Wells AU, O'Connor BJ: Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995;151:1889-1893.
15. Ho LP, Innes JA, Greening AP: Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998;53:680-684.
16. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F: Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 1998;78:49-53.
17. Balfour-Lynn IM, Laverty A, Dinwiddie R: Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996;75:319-322.
18. Grasemann H, Michler E, Wallot M, Ratjen F: Decreased concentration of exhaled nitric oxide in patients with cystic fibrosis. Pediatr Pulmonol 1997;24:173-177.
19. Ho LP, Innes JA, Greening AP: Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J 1998;12:1290-1294.
20. Linnane SJ, Keatings VM, Costello CM, Moynihan JB, O'Connor CM, Fitzgerald MX, McLoughlin P: Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 1998;158:207-212.
21. DeBlic J, Midulla F, Barbato A, Clement A, Dab I, Eber E, Green C, Grigg J, Kotecha S, Kurland G, Pohunek P, Ratjen F, Rossi G: Bronchoalveolar lavage in children. Eur Respir J 2000;15:217-231.
22. Salva PS, Doyle NA, Graham L, Eigen H, Doerschuk CM. TNF-α, IL-8, soluble ICAM-1 and neutrophils in sputum of cystic fibrosis patients. Pediatr Pulmonol 1996;21:11-19.
23. Grasemann H, Ioannidis I, de Groot H, Ratjen F: Metabolites of nitric oxide in the lower respiratory tract of children. Eur J Pediatr 1997;156:575-578.
24. Rennard SI, Ghafouri M, Thompson AB, Linder J, Vaughan W, Jones K, Ertl RF, Christensen K, Prince A, Stahl MG, Robbins RA: Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am Rev Respir Dis 1990;141:208-217.
25. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
26. Grasemann H, Gaston B, Fang K, Paul K, Ratjen F: Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J Pediatr 1999;135:770-772.
27. Konstan MW, Hilliard KA, Norvell TM, Berger M: Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994;150:448-454.
28. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M: Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-2118.
29. Cantin A: Cystic fibrosis lung inflammation. Am J Respir Crit Care Med 1995;151:939-941.
30. Francoeur C, Denis M: Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis. Inflammation 1995;19:587-598.
31. Jones KL, Bryan TW, Jinkins PA, Simpson KL, Grisham MB, Owens MW, Milligan SA, Markewitz BA, Robbins RA: Superoxide released from neutrophils causes a reduction in nitric oxide gas. Am J Physiol 1998;275:L1120-L1126.
32. Jöbsis Q, Raatgeep HC, Schellekens SL, Kroesbergen A, Hop WCJ, de Jongste JC: Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J 2000;16:95-100.
33. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW: Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-1082.
34. Richman-Eisenstat J: Cytokine soup: Making sense of inflammation in cystic fibrosis. Pediatr Pulmonol 1996;21:3-5.
35. Konstan MW, Berger M: Current understanding of the inflammatory process in cystic fibrosis. Pediatr Pulmonol 1997;24:137-142.
36. Weller PH: Implications of early inflammation and infection in cystic fibrosis. Pediatr Pulmonol 1997;24:143-146.
37. Dai Y, Dean T, Church M, Warner J, Shute J: Desensitisation of neutrophil responses by systemic IL-8 in cystic fibrosis. Thorax 1994;49:867-871.
38. 4 in serum of patients with cystic fibrosis. Pediatr Asthma Allergy Immunol 1996;10:101-107.
39. Greally P, Hussain M, Vergani D, Price J: IL-1α, soluble IL-2 receptor and IgG concentrations in cystic fibrosis treated with prednisolone. Arch Dis Child 1994;71:35-39.